Alder BioPharmaceuticals, Inc. is a clinical-stage biopharmaceutical company committed to transforming the treatment paradigm for patients with migraine and other serious neurological or inflammatory conditions.

PIPELINE

Eptinezumab and Migraine

Newswire

Menu
×